Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Chromocell Therapeutics Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CHRO
American
8731
https://chromocell.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Chromocell Therapeutics Corp
Chromocell Issues Letter to Stockholders from Chief Executive Officer
- Apr 9th, 2024 12:30 pm
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
- Mar 21st, 2024 12:30 pm
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
- Mar 18th, 2024 2:00 pm
Sidoti Events, LLC's Virtual March Small-Cap Conference
- Mar 12th, 2024 2:30 pm
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
- Mar 11th, 2024 1:00 pm
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
- Feb 27th, 2024 1:00 pm
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
- Feb 21st, 2024 9:47 pm
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
- Feb 16th, 2024 1:00 pm
Scroll